Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.

The entities involved

• Moderna →

  American biotechnology company

  • Analyst downgrades and market challenges are impacting Moderna amid waning demand for COVID-19 vaccines, alongside pipeline successes.Mon 17:09
  • Positive test results were reported for Moderna's flu vaccine.Sun 15:33
• Citigroup →

  American investment bank and financial services corporation

  • Citigroup provided analyst ratings and targets for Autodesk stock, which trades on Nasdaq.Mon 11:05
  • Citigroup and Jefferies Financial Group downgraded the stock rating for Yara International on June 26, 2026.Mon 10:14
• CLSA →

  Capital markets and investment group

  • Talks between the US and China are underway, where the current US trade status is the key factor in establishing a conditional truce to avert a trade war.Thu 06:34
  • UBS, HSBC, and CLSA issued various ratings and price targets for Bajaj Finance Ltd on July 31, 2026.Wed 06:49

Related events

• Citigroup reiterated a market outperform rating for KB Home.Aug 28
• Citigroup raised price targets and ratings for Rayonier on September 11, 2026.Sep 12
• Citigroup raised its price objective on the shares of Integer Holdings Corporation on September 1, 2026.Sep 17
• MarketBeat provided average rating data for Moderna, while CLSA raised the rating and Jefferies reiterated a hold.Sep 11
• Citigroup upgraded the stock rating for Truist Financial on June 26, 2025.Jun 8